Skip to Content

Acro Biomedical Co Ltd ACBM

Morningstar Rating
$0.11 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ACBM is trading at a 57% discount.
Price
$0.10
Fair Value
$6.35
Uncertainty
Extreme
1-Star Price
$6.16
5-Star Price
$1.37
Economic Moat
Npzwjqv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ACBM is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.11
Day Range
$0.110.11
52-Week Range
$0.114.50
Bid/Ask
$0.01 / $2.00
Market Cap
$6.30 Mil
Volume/Avg
300 / 5,159

Key Statistics

Price/Earnings (Normalized)
Price/Sales
17.51
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Acro Biomedical Co Ltd develops and manufactures nutritional products. The company offers cordyceps fungus for medicinal purposes. It also sells cordycepin and cordyceps powder.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Total Number of Employees
1

Comparables

Valuation

Metric
ACBM
VSBC
SCLX
Price/Earnings (Normalized)
3,629.76
Price/Book Value
4.671,908.62
Price/Sales
17.51664.532.65
Price/Cash Flow
2,904.34
Price/Earnings
ACBM
VSBC
SCLX

Financial Strength

Metric
ACBM
VSBC
SCLX
Quick Ratio
2.514.320.15
Current Ratio
2.644.330.19
Interest Coverage
−5,289.20−106.04
Quick Ratio
ACBM
VSBC
SCLX

Profitability

Metric
ACBM
VSBC
SCLX
Return on Assets (Normalized)
−37.24%42.38%−106.47%
Return on Equity (Normalized)
−2.74%65.38%
Return on Invested Capital (Normalized)
−48.36%55.23%−1,960.39%
Return on Assets
ACBM
VSBC
SCLX
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MCK
McKesson CorpZktdkcjkHjpbdhk$69.0 Bil
COR
Cencora IncKlrrftlmBstzhh$47.2 Bil
CAH
Cardinal Health IncKrldwsntlQtglql$26.3 Bil
SHPMY
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class HNzvxwmk$8.2 Bil
SHPMF
Shanghai Pharmaceuticals Holding Co Ltd Class HKwznsxl$8.0 Bil
SHTDY
Sinopharm Group Co Ltd ADRTyjwfq$7.9 Bil
SHTDF
Sinopharm Group Co LtdNnvsn$7.9 Bil
AMFPF
Amplifon SpA Az nom Post FrazionamentoNjtycbs$7.6 Bil
MAHLY
Medipal Holdings Corp ADRWpqz$3.3 Bil
MEPDF
Medipal Holdings CorpPqmv$3.2 Bil

Sponsor Center